Investor Q&A Series: Roel Bulthuis, INKEF Capital
In our first Investor Q&A article, Roel Bulthuis, Managing Partner of INKEF Capital shares his thoughts on the investment landscape in Europe.
In our first Investor Q&A article, Roel Bulthuis, Managing Partner of INKEF Capital shares his thoughts on the investment landscape in Europe.
One Nucleus’ BioWednesday Webinar discussed what R&D is underway to treat the effects of concussions, how new technologies are enabling better diagnoses…
New funding is available for the UK’s most promising life sciences companies, with the potential to crowd in further funding from other investors…
Optimum is proud to partner with The LSX Nordic Congress, one of the leading strategy, investment and partnering conference for the Nordic life science and healthcare industry. Register now…
To celebrate, we asked the brilliant women in our sector their one main positive to come from the pandemic.